• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性蛋白D与血清共凝集素融合蛋白的抗流感活性增强

Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein.

作者信息

Hartshorn K L, Sastry K N, Chang D, White M R, Crouch E C

机构信息

Departments of Medicine and Pathology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L90-8. doi: 10.1152/ajplung.2000.278.1.L90.

DOI:10.1152/ajplung.2000.278.1.L90
PMID:10645895
Abstract

We previously demonstrated that bovine serum conglutinin has markedly greater ability to inhibit influenza A virus (IAV) infectivity than other collectins. We now show that recombinant conglutinin and a chimeric protein containing the NH(2) terminus and collagen domain of rat pulmonary surfactant protein D (rSP-D) fused to the neck region and carbohydrate recognition domain (CRD) of conglutinin (termed SP-D/Cong(neck+CRD)) have markedly greater ability to inhibit infectivity of IAV than wild-type recombinant rSP-D, confirming that the potent IAV-neutralizing activity of conglutinin resides in its neck region and CRD. Furthermore, by virtue of incorporation of the NH(2) terminus and collagen domain of SP-D, SP-D/Cong(neck+CRD) caused substantially greater aggregation of IAV particles and enhancement of neutrophil binding of, and H(2)O(2) responses to, IAV than recombinant conglutinin or recombinant rSP-D. Hence, SP-D/Cong(neck+CRD) combined favorable antiviral and opsonic properties of conglutinin and SP-D. This study demonstrates an association of specific structural domains of SP-D and conglutinin with specific functional properties and illustrates that antimicrobial activities of wild-type collectins can be enhanced through recombinant strategies.

摘要

我们之前证明,牛血清胶固素比其他凝集素具有更强的抑制甲型流感病毒(IAV)感染性的能力。我们现在表明,重组胶固素以及一种嵌合蛋白,该嵌合蛋白包含大鼠肺表面活性物质蛋白D(rSP-D)的NH₂末端和胶原结构域,并与胶固素的颈部区域和碳水化合物识别结构域(CRD)融合(称为SP-D/Cong(neck+CRD)),其抑制IAV感染性的能力比野生型重组rSP-D明显更强,这证实了胶固素强大的IAV中和活性存在于其颈部区域和CRD中。此外,由于并入了SP-D的NH₂末端和胶原结构域,SP-D/Cong(neck+CRD)比重组胶固素或重组rSP-D能引起IAV颗粒更大程度的聚集,并增强中性粒细胞对IAV的结合以及对IAV的H₂O₂反应。因此,SP-D/Cong(neck+CRD)兼具了胶固素和SP-D良好的抗病毒和调理特性。本研究证明了SP-D和胶固素的特定结构域与特定功能特性之间的关联,并表明通过重组策略可以增强野生型凝集素的抗菌活性。

相似文献

1
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein.表面活性蛋白D与血清共凝集素融合蛋白的抗流感活性增强
Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L90-8. doi: 10.1152/ajplung.2000.278.1.L90.
2
Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera.人甘露糖结合凝集素与表面活性蛋白D嵌合体的抗病毒活性及调理活性增强
J Immunol. 2000 Aug 15;165(4):2108-15. doi: 10.4049/jimmunol.165.4.2108.
3
Complementation of pulmonary abnormalities in SP-D(-/-) mice with an SP-D/conglutinin fusion protein.用SP-D/凝集素融合蛋白对SP-D(-/-)小鼠肺部异常进行互补。
J Biol Chem. 2002 Jun 21;277(25):22453-9. doi: 10.1074/jbc.M201632200. Epub 2002 Apr 15.
4
Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.表面活性蛋白D的N端和C端结构域对细菌的结合、聚集和吞噬摄取的作用。
Infect Immun. 2002 Nov;70(11):6129-39. doi: 10.1128/IAI.70.11.6129-6139.2002.
5
Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.表面活性蛋白A和D的抗流感活性机制:与血清凝集素的比较
Am J Physiol. 1997 Dec;273(6):L1156-66. doi: 10.1152/ajplung.1997.273.6.L1156.
6
Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus.截短的人表面活性蛋白D的结构在凝集细菌方面比天然结构的效果差,并且无法抑制甲型流感病毒的血细胞凝集。
Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):393-9. doi: 10.1042/bj3230393.
7
Distinctive anti-influenza properties of recombinant collectin 43.重组凝集素43独特的抗流感特性
Biochem J. 2002 Aug 15;366(Pt 1):87-96. doi: 10.1042/BJ20011868.
8
Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies.甲型流感病毒导致的中性粒细胞失活:经凝集素和血凝抑制抗体进行病毒调理作用后的保护机制
Blood. 1996 Apr 15;87(8):3450-61.
9
Conglutinin acts as an opsonin for influenza A viruses.胶固素作为甲型流感病毒的调理素。
J Immunol. 1993 Dec 1;151(11):6265-73.
10
Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus.缺乏N端和胶原结构域的重组牛凝集素,其凝集活性较低,但能够抑制甲型流感病毒的血凝反应。
Biochem J. 1996 May 15;316 ( Pt 1)(Pt 1):43-8. doi: 10.1042/bj3160043.

引用本文的文献

1
T Cell Responses to Influenza Infections in Cattle.牛对流感感染的T细胞反应。
Viruses. 2025 Aug 14;17(8):1116. doi: 10.3390/v17081116.
2
Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19.先天免疫与甲型流感病毒发病机制:对 COVID-19 的启示。
Front Cell Infect Microbiol. 2020 Oct 22;10:563850. doi: 10.3389/fcimb.2020.563850. eCollection 2020.
3
Atomic-resolution crystal structures of the immune protein conglutinin from cow reveal specific interactions of its binding site with -acetylglucosamine.
牛免疫蛋白血纤维蛋白原的原子分辨率晶体结构揭示了其结合位点与 N-乙酰葡萄糖胺的特定相互作用。
J Biol Chem. 2019 Nov 8;294(45):17155-17165. doi: 10.1074/jbc.RA119.010271. Epub 2019 Sep 27.
4
The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.表面活性蛋白D在宿主抗甲型流感病毒天然免疫防御中的作用及分子作用机制
Front Immunol. 2018 Jun 13;9:1368. doi: 10.3389/fimmu.2018.01368. eCollection 2018.
5
Arginine-rich histones have strong antiviral activity for influenza A viruses.富含精氨酸的组蛋白对甲型流感病毒具有强大的抗病毒活性。
Innate Immun. 2015 Oct;21(7):736-45. doi: 10.1177/1753425915593794. Epub 2015 Jul 2.
6
The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.表面活性剂在肺部疾病及宿主抵御肺部感染中的作用
Ann Am Thorac Soc. 2015 May;12(5):765-74. doi: 10.1513/AnnalsATS.201411-507FR.
7
Human lectins and their roles in viral infections.人类凝集素及其在病毒感染中的作用。
Molecules. 2015 Jan 29;20(2):2229-71. doi: 10.3390/molecules20022229.
8
Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study.重组嵌合凝集素(由甘露糖结合凝集素和 L- 纤维胶凝素组成)对流感 A 病毒感染的小鼠模型研究的疗效。
Virus Res. 2013 Dec 26;178(2):495-501. doi: 10.1016/j.virusres.2013.10.001. Epub 2013 Oct 16.
9
The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.补体凝集素途径在锥虫中的新作用:激活的分子基础、基因缺陷、感染易感性及基于补体系统的治疗方法
ScientificWorldJournal. 2013;2013:675898. doi: 10.1155/2013/675898. Epub 2013 Feb 21.
10
The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.人源抗菌肽 LL-37 通过与表面活性剂蛋白 D 或防御素不同的机制抑制甲型流感病毒。
J Gen Virol. 2013 Jan;94(Pt 1):40-49. doi: 10.1099/vir.0.045013-0. Epub 2012 Oct 10.